Serological markers of persistent C-trachomatis infections in women with tubal factor subfertility

被引:60
作者
den Hartog, JE
Land, JA
Stassen, FRM
Kessels, AGH
Bruggeman, CA
机构
[1] Acad Ziekenhuis Maastricht, Res Inst Growth & Dev, NL-6202 AZ Maastricht, Netherlands
[2] Acad Ziekenhuis Maastricht, Dept Obstet & Gynecol, NL-6202 AZ Maastricht, Netherlands
[3] Acad Ziekenhuis Maastricht, Maastricht Infect Ctr, NL-6202 AZ Maastricht, Netherlands
[4] Acad Ziekenhuis Maastricht, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands
[5] Acad Ziekenhuis Maastricht, Dept Clin Epidemiol & Med technol Assessment KEMT, NL-6202 AZ Maastricht, Netherlands
关键词
Chlamydia trachomatis; chlamydia heat shock protein 60; C-reactive protein; immunoglobulin A; persistent infection;
D O I
10.1093/humrep/deh710
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Persistent C. trachomatis infections are assumed to increase the risk of tubal pathology. We studied whether serological markers, assumed to be associated with persistent C. trachomatis infections, could identify subfertile women at risk of tubal pathology. METHODS: Sera of 313 subfertile women, who all underwent a laparoscopy with tubal testing to assess the grade of tubal pathology, were tested for the presence of immunoglobulin (Ig) G and IgA antibodies to C. trachomatis, IgG antibodies to chlamydia heat shock protein 60 (cHSP60) and C-reactive protein (CRP). RESULTS: C. trachomatis IgA, cHSP60 IgG and CRP, all serological markers of persistent infections, were significantly more prevalent in women with tubal pathology as compared to those without tubal pathology. The predictive value of the currently used screening test for tubal pathology (IgG to C. trachomatis) could be significantly improved by adding the CRP test. CONCLUSIONS: In subfertile women with tubal pathology, serological markers of persistent C. trachomatis infections are significantly more common as compared to women without tubal pathology. C. trachomatis IgG-positive subfertile women with slightly elevated (< 10 mg/l) CRP levels are at highest risk of persistent C. trachomatis infections and tubal pathology.
引用
收藏
页码:986 / 990
页数:5
相关论文
共 25 条
[11]  
GRAYSTON JT, 1985, REV INFECT DIS, V7, P717
[12]   C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis [J].
Johnston, SC ;
Messina, LM ;
Browner, WS ;
Lawton, MT ;
Morris, C ;
Dean, D .
STROKE, 2001, 32 (12) :2748-2752
[13]   HEAT-SHOCK PROTEINS AND THE IMMUNE-RESPONSE [J].
KAUFMANN, SHE .
IMMUNOLOGY TODAY, 1990, 11 (04) :129-136
[14]   Performance of five serological chlamydia antibody tests in subfertile women [J].
Land, JA ;
Gijsen, AP ;
Kessels, AGH ;
Slobbe, MEP ;
Bruggeman, CA .
HUMAN REPRODUCTION, 2003, 18 (12) :2621-2627
[15]   How to use Chlamydia antibody testing in subfertility patients [J].
Land, JA ;
Evers, JLH ;
Goossens, VJ .
HUMAN REPRODUCTION, 1998, 13 (04) :1094-1098
[16]   The natural course of asymptomatic Chlamydia trachomatis infections:: 45% clearance and no development of clinical PID after one-year follow-up [J].
Morré, SA ;
van den Brule, AJC ;
Rozendaal, L ;
Boeke, AJP ;
Voorhorst, FJ ;
de Blok, S ;
Meijer, CJLM .
INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 :12-18
[17]   CHLAMYDIAL DISEASE PATHOGENESIS - OCULAR HYPERSENSITIVITY ELICITED BY A GENUS-SPECIFIC 57-KD PROTEIN [J].
MORRISON, RP ;
LYNG, K ;
CALDWELL, HD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) :663-675
[18]   DETECTION OF CHLAMYDIA-TRACHOMATIS IN FALLOPIAN-TUBE TISSUE IN WOMEN WITH POSTINFECTIOUS TUBAL INFERTILITY [J].
PATTON, DL ;
ASKIENAZYELBHAR, M ;
HENRYSUCHET, J ;
CAMPBELL, LA ;
CAPPUCCIO, A ;
TANNOUS, W ;
WANG, SP ;
KUO, CC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (01) :95-101
[19]   DEMONSTRATION OF DELAYED-HYPERSENSITIVITY IN CHLAMYDIA-TRACHOMATIS SALPINGITIS IN MONKEYS - A PATHOGENIC MECHANISM OF TUBAL DAMAGE [J].
PATTON, DL ;
SWEENEY, YTC ;
KUO, CC .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03) :680-683
[20]   Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].
Pearson, TA ;
Mensah, GA ;
Alexander, RW ;
Anderson, JL ;
Cannon, RO ;
Criqui, M ;
Fadl, YY ;
Fortmann, SP ;
Hong, Y ;
Myers, GL ;
Rifai, N ;
Smith, SC ;
Taubert, K ;
Tracy, RP ;
Vinicor, F .
CIRCULATION, 2003, 107 (03) :499-511